In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci

Journal of Infectious Diseases

Volumn 190, Issue 12, 2004, Pages 2162-2166

  Rice, Louis B ^a,b,c   Lakǐicová, Viera ^a   Helfand, Marion S ^a   Hutton Thomas, Rebecca ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; PIPERACILLIN PLUS TAZOBACTAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DOSE RESPONSE; ENTEROCOCCUS FAECIUM; FEMALE; GASTROINTESTINAL INFECTION; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL;

ANIMALS; ANTI-BACTERIAL AGENTS; CARRIER STATE; CEFTRIAXONE; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECIUM; FECES; FEMALE; GASTROINTESTINAL TRACT; GRAM-POSITIVE BACTERIAL INFECTIONS; MICE; PENICILLANIC ACID; PIPERACILLIN;

EID: 10444241229     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/425580     Document Type: Article

References (20)

1. Wells CL, Juni BA, Cameron SB, et al. Stool carriage, clinical isolation, and mortality during an outbreak of vancomycin-resistant enterococci in hospitalized medical and/or surgical patients. Clin Infect Dis 1995; 21:45-50.
2. Bradley SJ, Wilson AL, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999; 43:261-6.
3. Puzniak LA, Mayfield J, Leet T, Kollef M, Mundy LM. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. Clin Infect Dis 2001; 33:151-7.
4. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 2001; 135:175-83.
5. Moreno F, Grota P, Crisp C, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995; 21:1234-7.
6. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999; 180:384-90.
7. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 2000; 181:1830-3.
8. Rice LB, Hutton-Thomas R, Lakticova V, Helfand MS, Donskey CJ. β-Lactam antibiotics and gastrointestinal colonization with vancomycin-resistant enterococci. J Infect Dis 2004; 189:1113-8.
9. Donskey CJ, Schreiber JR, Jacobs MR, et al. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Clin Infect Dis 1999; 29:573-9.
10. Taylor EW, Poxon V, Alexander-Williams J, Jackson D. Biliary excretion of piperacillin. J Int Med Res 1983; 11:28-31.
11. Hayton WL, Schandlik R, Stoeckel K. Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy. Eur J Clin Pharmacol 1986; 30:445-51.
12. Carias LL, Rudin SD, Donskey CJ, Rice LB. Genetic linkage and cotransfer of a novel, vanB-containing transposon (Tn5382) and a low-affinity penicillin-binding protein 5 gene in a clinical vancomycin-resistant Enterococcus faecium isolate. J Bacteriol 1998; 180:4426-34.
13. Rice LB, Carias LL, Hutton-Thomas R, Sifaoui F, Gutmann L, Rudin SD. Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium. Antimicrob Agents Chemother 2001; 45:1480-6.
14. Efm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003; 187:508-12.
15. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphyhcoccus aureus containing the vanA resistance gene. N Engl J Med 2003; 348:1342-7.
16. Weigel LM, Clewell DB, Gill SR, et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 2003; 302:1569-71.
17. Sahm DF, Marsilio MK, Piazza G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database-USA. Clin Infect Dis 1999; 29:259-63.
18. Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance: report from the Hospital Infection Control Practices Advisory Committee. Fed Regist 1994; 59:25758-63.
19. Grayson ML, Eliopoulos GM, Wennersten CB, et al. Increasing resistance to β-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother 1991; 35:2180-4.
20. Chirurgi VA, Oster SE, Goldberg AA, McCabe RE. Nosocomial acquisition of β-lactamase-negative, ampicillin-resistant enterococcus. Arch Intern Med 1992; 152:1457-61.